Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

New fluorescent assay distinguishes between AML, ALL, and normal cells

Key clinical point: Two forms of acute leukemia (AML and ALL) could be distinguished from normal cells.

Major finding: AML and ALL could be distinguished from normal cells with 88% sensitivity and 80% specificity.

Study details: Analysis of fluorescence spectra of blood plasma and red blood cell samples from 85 patients.

Disclosures: The study was funded by King Saud University, Riyadh, Saudi Arabia. The author’s declared that they have no competing interests but stated that the main result of the study is patent-pending in the United States.

Citation:

Masilamani V et al. Photodiagnosis and Photodynamic Therapy. 2020;29: doi.org/10.1016/j.pdpdt.2019.101634.